CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-03 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 100,410 | ||
| 2026-11-02 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-11-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −223 | $593.09 | $132K | 333,720 |
| 2026-11-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −905 | $594.03 | $538K | 332,815 |
| 2026-11-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,599 | $595.15 | $952K | 331,216 |
| 2026-11-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,776 | $596.11 | $1.7M | 328,440 |
| 2026-11-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,517 | $597.02 | $1.5M | 325,923 |
| 2026-11-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,280 | $597.95 | $765K | 324,643 |
| 2026-11-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −200 | $598.84 | $120K | 324,443 |
| 2026-11-02 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 109,910 | ||
| 2026-10-30 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-10-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −119 | $594.92 | $71K | 333,824 |
| 2026-10-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −728 | $596.01 | $434K | 333,096 |
| 2026-10-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −393 | $596.84 | $235K | 332,703 |
| 2026-10-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,496 | $598.04 | $895K | 331,207 |
| 2026-10-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −884 | $598.94 | $529K | 330,323 |
| 2026-10-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,200 | $600.25 | $720K | 329,123 |
| 2026-10-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,742 | $600.96 | $1.0M | 327,381 |
| 2026-10-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,018 | $601.94 | $1.2M | 325,363 |
| 2026-10-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −577 | $603.13 | $348K | 324,786 |
Page 9 of 64 · 1,267 trades